COVID-19 vaccine manufacturers capture less than 2% of total social value
How can we best accelerate vaccine availability? This is the question that Ahuja et al. (2021) try to answer in their Becker-Friedman Institute (BFI) working paper. First, they state the obvious: the cost of the COVID-19 pandemic is large. Specifically: Each month, the COVID pandemic kills 300,000 people (as of Jan. 2021) and reduces global…